[1] 梁萌,陈治军.糖皮质激素与臭氧硬膜外腔注射治疗椎间盘源性神经痛的比较性研究[J].颈腰痛杂志,2018,39(5):660-661.
[2] NAVANI A, MANCHIKANTI L, ALBERS SL, et al. Responsible, safe, and effective use of biologics in the management of low back pain: American society of interventional pain physicians (ASIPP) guidelines. Pain Physician. 2019;22(1S):S1-S74.
[3] MEYER-FRIEßEM CH, EITNER LB, KAISLER M, et al. Perineural injection of botulinum toxin-A in painful peripheral nerve injury - a case series: pain relief, safety, sensory profile and sample size recommendation. Curr Med Res Opin. 2019;35(10):1793-1803.
[4] WANG L, HE T, LIU J, et al. Revealing the immune infiltration landscape and identifying diagnostic biomarkers for lumbar disc herniation. Front Immunol. 2021;12:666355.
[5] NAKAZAWA KR, WALTER BA, LAUDIER DM, et al. Accumulation and localization of macrophage phenotypes with human intervertebral disc degeneration. Spine J. 2018;18(2):343-356.
[6] 陈开广,刘群会,陈绣娟,等.射频热凝并骶管注射对椎间盘源性腰神经痛的治疗作用[J].中国康复医学杂志,2006,21(8):736-737.
[7] STEFFEN F, BERTOLO A, AFFENTRANGER R, et al. Treatment of naturally degenerated canine lumbosacral intervertebral discs with autologous mesenchymal stromal cells and collagen microcarriers: a prospective clinical study. Cell Transplant. 2019;28(2):201-211.
[8] 庞胤,尹帅,赵长义,等.脊柱腰段三维有限元模型的构建与椎间盘应力分析[J].河北医科大学学报,2019,40(12):1368-1371.
[9] WANG AM, CAO P, YEE A, et al. Detection of extracellular matrix degradation in intervertebral disc degeneration by diffusion magnetic resonance spectroscopy. Magn Reson Med. 2015;73(5):1703-1712.
[10] KIM H, HONG JY, LEE J, et al. IL-1β promotes disc degeneration and inflammation through direct injection of intervertebral disc in a rat lumbar disc herniation model. Spine J. 2021;21(6):1031-1041.
[11] 秦大平,张晓刚,聂文忠,等.不同运动状态下模拟人体腰椎结构特征变化的有限元分析[J].医用生物力学,2017,32(4):355-362.
[12] 冯阳,严旭,王永魁,等.腰椎间盘退变性疾病与外周血淋巴细胞亚群的关系[J].中国组织工程研究,2020,24(17):2630-2635.
[13] JOYCE K, MOHD ISA IL, KROUWELS A, et al. The role of altered glycosylation in human nucleus pulposus cells in inflammation and degeneration. Eur Cell Mater. 2021;41:401-420.
[14] XU Z, ZHOU X, CHEN G. Expression and mechanism of interleukin 1 (IL-1), interleukin 2 (IL-2), interleukin 8 (IL-8), BMP, fibroblast growth factor 1 (FGF1), and insulin-like growth factor (IGF-1) in lumbar disc herniation. Med Sci Monit. 2019;25:984-990.
[15] SUN Z, LIU B, LUO ZJ. The immune privilege of the intervertebral disc: implications for intervertebral disc degeneration Treatment. Int J Med Sci. 2020;17(5):685-692.
[16] SCHROEDER GD, MARKOVA DZ, KOERNER JD, et al. Are modic changes associated with intervertebral disc cytokine profiles? Spine J. 2017;17(1):129-134.
[17] JOHNSON ZI, SCHOEPFLIN ZR, CHOI H, et al. Disc in flames: roles of TNF-α and IL-1β in intervertebral disc degeneration. Eur Cell Mater. 2015;30:104-117.
[18] WANG C, YU X, YAN Y, et al. Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration. Acta Biochim Biophys Sin. 2017; 49(1):1-13.
[19] YANG W, YU XH, WANG C, et al. Interleukin-1β in intervertebral disk degeneration. Clin Chim Acta. 2015;450:262-272.
[20] XIE J, LI B, YAO B, et al. Transforming growth factor-β1-regulated Fas/FasL pathway activation suppresses nucleus pulposus cell apoptosis in an inflammatory environment. Biosci Rep. 2020;40(2):BSR20191726.
[21] LEE JM, SONG JY, BAEK M, et al. Interleukin-1β induces angiogenesis and innervation in human intervertebral disc degeneration. J Orthop Res. 2011;29(2):265-269.
[22] SUN Z, ZHANG M, ZHAO XH, et al. Immune cascades in human intervertebral disc: the pros and cons. Int J Clin Exp Pathol. 2013;6(6): 1009-1014.
[23] MALCANGIO M. Role of the immune system in neuropathic pain. Scand J Pain. 2019;20(1):33-37.
[24] OZAKI-SAITOH H, TSUDA M. Microglia-neuron interactions in the models of neuropathic pain. Biochem Pharmacol. 2019;169:113614.
[25] MURPHY RW. Nerve roots and spinal nerves in degenerative disk disease. Clin Orthop Relat Res. 1977;(129):46-60.
[26] DOWER A, DAVIES MA, GHAHREMAN A. Pathologic basis of lumbar radicular pain. World Neurosurg. 2019;128:114-121.
[27] BOBECHKO WP, HIRSCH C. Auto-immune response to nucleus pulposus in the rabbit. J Bone Joint Surg Br. 1965;47:574-580.
[28] NAYLOR A, HAPPEY F, TURNER RL, et al. Enzymic and immunological activity in the intervertebral disk. Orthop Clin North Am. 1975;6(1):51-58.
[29] SPILIOPOULOU I, KOROVESSIS P, KONSTANTINOU D, et al. IgG and IgM concentration in the prolapsed human intervertebral disc and sciatica etiology. Spine. 1994;19(12):1320-1323.
[30] SATOH K, KONNO S, NISHIYAMA K, et al. Presence and distribution of antigen-antibody complexes in the herniated nucleus pulposus. Spine. 1999;24:1980-1984.
[31] GEISS A, LARSSON K, RYDEVIK B, et al. Autoimmune properties of nucleus pulposus: an experimental study in pigs. Spine. 2007;32:168-173.
[32] 曹涌,姚羽,张烽.腰椎间盘突出症与Th细胞、NK细胞的相关性研究[J].中国脊柱脊髓杂志,2013,23(10):912-915.
[33] CAPOSSELA S, SCHLAFLI P, BERTOLO A, et al. Degenerated human intervertebral discs contain autoantibodies against extracellular matrix proteins. Eur Cell Mater. 2014;27:251-263.
[34] 欧阳冰,苏建成,曾月东,等.退变腰椎间盘组织中炎症因子IL-6、IL-10及MCP-1的表达变化及意义[J]. 海南医学院学报,2014, 20(3):381-383.
[35] STICH S, STOLK M, GIROD PP, et al. Regenerative and immunogenic characteristics of cultured nucleus pulposus cells from human cervical intervertebral discs. PLoS One. 2015;10(5):e0126954.
[36] 刘振刚,卢一生,施建东,等.腰椎间盘突出症和椎间盘源性疼痛的免疫病理学研究[J].颈腰痛杂志,2016,37(4):272-275.
[37] MONCHAUX M, FORTERRE S, SPRENG D, et al. Inflammatory processes associated with canine intervertebral disc herniation. Front Immunol. 2017; 8:1681.
[38] WANG S, WEI J, FAN Y, et al. Progranulin is positively associated with intervertebral disc degeneration by interaction with IL-10 and IL-17 through TNF pathways. Inflammation. 2018;41(5):1852-1863.
[39] HASVIK E, SCHJØLBERG T, JACOBSEN DP, et al. Up-regulation of circulating microRNA-17 is associated with lumbar radicular pain following disc herniation. Arthritis Res Ther. 2019;21(1):186.
[40] SILVA AJ, FERREIRA JR, CUNHA C, et al. Macrophages down-regulate gene expression of intervertebral disc degenerative markers under a pro-inflammatory microenvironment. Front Immunol. 2019;10:1508.
[41] LEE S, MILLECAMPS M, FOSTER DZ, et al. Long-term histological analysis of innervation and macrophage infiltration in a mouse model of intervertebral disc injury-induced low back pain. J Orthop Res. 2020; 38(6):1238-1247.
[42] CHENG J, SANTIAGO KA, NGUYEN JT, et al. Treatment of symptomatic degenerative intervertebral discs with autologous platelet-rich plasma: follow-up at 5-9 years. Regen Med. 2019;14(9):831-840.
[43] CHANG MC, PARK D. The effect of intradiscal platelet-rich plasma injection for management of discogenic lower back pain: a meta-analysis. J Pain Res. 2021;14:505-512.
[44] BASTAMI F, VARES P, KHOJASTEH A. Healing effects of platelet-rich plasma on peripheral nerve injuries. J Craniofac Surg. 2017;28(1):e49-e57.
[45] GIUSTI I, D’ASCENZO S, MACCHIARELLI G, et al. In vitro evidence supporting applications of platelet derivatives in regenerative medicine. Blood Transfus. 2020;18(2):117-129.
[46] 阚厚铭,范利君,陈学泰,等.富血小板血浆在神经病理性疼痛中的应用[J].中国组织工程研究,2022,26(8):1345-1353.
[47] ZAFARNIA S, BZYL-IBACH J, SPIVAK I, et al. Nilotinib enhances tumor angiogenesis and counteracts VEGFR2 blockade in an orthotopic breast cancer xenograft model with desmoplastic response. Neoplasia. 2017;19(11):896-907.
[48] HANLEY EN JR, HERKOWITZ HN, KIRKPATRICK JS, et al. Debating the value of spine surgery. J Bone Joint Surg Am. 2010;92(5):1293-1304.
[49] KIRCHNER F, PINAR A, MILANI I, et al. Vertebral intraosseous plasma rich in growth factor (PRGF-Endoret) infiltrations as a novel strategy for the treatment of degenerative lesions of endplate in lumbar pathology: description of technique and case presentation. J Orthop Surg Res. 2020;15(1):72.
[50] 董晤讯,马勇,郭杨,等.富血小板血浆对兔腰背根神经节细胞凋亡的影响[J].安徽医药,2020,24(7):1374-1377.
[51] CHANG NJ, ERDENEKHUYAG Y, CHOU PH, et al. Therapeutic effects of the addition of platelet-rich plasma to bioimplants and early rehabilitation exercise on articular cartilage repair. Am J Sports Med. 2018;46(9):2232-2241.
[52] ZHANG J, WANG JH. PRP treatment effects on degenerative tendinopathy - an in vitro model study. Muscles Ligaments Tendons J. 2014;4(1):10-17.
[53] MCGREGOR CE, IRWIN AM, ENGLISH AW. The val66met BDNF polymorphism and peripheral nerve injury: enhanced regeneration in mouse met-carriers is not further improved with activity-dependent treatment. Neurorehabil Neural Repair. 2019;33(6):407-418.
[54] DEMBO T, BRAZ JM, HAMEL KA, et al. Primary afferent-derived BDNF contributes minimally to the processing of pain and itch. eNeuro. 2018;5(6):ENEURO.0402-18.2018.
[55] ENTERRÍA-MORALES D, LÓPEZ-LÓPEZ I, LÓPEZ-BARNEO J, et al. Striatal GDNF production is independent to circulating estradiol level despite pan-neuronal activation in the female mouse. PLoS One. 2016;11(10): e0164391.
[56] MOUSSA M, LAJEUNESSE D, HILAL G, et al. Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Exp Cell Res. 2017;352(1):146-156.
[57] AYADI AE, ZIGMOND MJ, SMITH AD. IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases. Exp Brain Res. 2016;234(7):1863-1873.
[58] TEYMUR H, TIFTIKCIOGLU YO, CAVUSOGLU T, et al. Effect of platelet-rich plasma on reconstruction with nerve autografts. Kaohsiung J Med Sci. 2017 33(2):69-77.
[59] EVERTS P, ONISHI K, JAYARAM P, et al. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794.
[60] ACOSTA-RODRIGUEZ EV, NAPOLITANI G, LANZAVECCHIA A, et al. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007;8(9):942-949.
[61] LIN W, LIU T, WANG B, et al. The role of ocular dendritic cells in uveitis. Immunol Lett, 2019, 209: 4-10.
[62] CHUDNOVSKIY A, PASQUAL G, VICTORA GD. Studying interactions between dendritic cells and T cells in vivo. Curr Opin Immunol. 2019; 58:24-30.
[63] HERTER JM, ROSSAINT J, ZARBOCK A. Platelets in inflammation and immunity. J Thromb Haemost. 2014;12(11):1764-1775.
[64] COGNASSE F, LARADI S, BERTHELOT P, et al. Platelet Inflammatory response to stress. Front Immunol. 2019;10:1478.
[65] 赵雪颖,张立媛,王育文.血小板与中性粒细胞的配-受体结合及信号传导[J].中国免疫学杂志,2021,37(22):2730-2733.
[66] HUANG J, LI X, SHI X, et al. Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting. J Hematol Oncol. 2019;12(1):26.
[67] IBERG CA, HAWIGER D. Natural and induced tolerogenic dendritic cells. J Immunol. 2020;204(4):733-744.
[68] SCHIRA J, HEINEN A, POSCHMANN G, et al. Secretome analysis of nerve repair mediating Schwann cells reveals smad-dependent trophism. FASEB J. 2019;33(4):4703-4715.
[69] PATEL NP, LYON KA, HUANG JH. An update-tissue engineered nerve grafts for the repair of peripheral nerve injuries. Neural Regen Res. 2018;13(5):764-774.
[70] LAI F, KAKUDO N, MORIMOTO N, et al. Platelet-rich plasma enhances the proliferation of human adipose stem cells through multiple signaling pathways. Stem Cell Res Ther. 2018;9(1):107.
[71] OYA T, ZHAO YL, TAKAGAWA K, et al. Platelet-derived growth factor-b expression induced after rat peripheral nerve injuries. Glia. 2002;38(4):303-312.
[72] ZHENG C, ZHU Q, LIU X, et al. Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. J Tissue Eng Regen Med. 2016;10(5):428-436.
[73] AL-MASSRI KF, AHMED LA, EL-ABHAR HS. Mesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathway. Behav Brain Res. 2019;360: 303-311.
[74] YE F, LI H, QIAO G, et al. Platelet-rich plasma gel in combination with schwann cells for repair of sciatic nerve injury. Neural Regen Res. 2012; 7(29):2286-2292.
[75] OGUNDELE OM, PARDO J, FRANCIS J, et al. A putative mechanism of age-related synaptic dysfunction based on the impact of IGF-1 receptor signaling on synaptic CaMKIIα phosphorylation. Front Neuroanat. 2018; 12:35.
[76] CASTRO MV, SILVA MVRD, CHIAROTTO GB, et al. Reflex arc recovery after spinal cord dorsal root repair with platelet rich plasma (PRP). Brain Res Bull. 2019;152:212-224.
[77] SINGH S, PATEL AA, SINGH JR. Intervertebral Disc degeneration: the role and evidence for Nnon-stem-cell-based regenerative therapies. Int J Spine Surg. 2021;15(s1):54-67.
[78] RAWSON B. Platelet-Rich Plasma and Epidural Platelet lysate: novel treatment for lumbar disk herniation. J Am Osteopath Assoc. 2020; 120(3):201-207.
[79] ANITUA E, PRADO R, MURUZABAL F. Why dilute the regenerative power of platelet-rich plasma? J Craniomaxillofac Surg. 2019;47(3):530-531.
[80] 杜薇,丁宇,崔洪鹏,等.经皮内窥镜下椎间盘摘除联合富血小板血浆凝胶微球置入治疗腰椎间盘突出症的疗效观察[J].中国脊柱脊髓杂志,2020,30(11):1001-1006.
[81] LIU C, CHAN C. An Approach to enhance alignment and myelination of dorsal root ganglion neurons. J Vis Exp. 2016;(114):54085.
[82] HUANG H, LIU H, YAN R, et al. PI3K/Akt and ERK/MAPK signaling promote different aspects of neuron survival and axonal regrowth following rat facial nerve axotomy. Neurochem Res. 2017;42(12):3515-3524.
[83] MUTHU S, JEYARAMAN M, CHELLAMUTHU G, et al. Does the intradiscal injection of platelet rich plasma have any beneficial role in the management of lumbar disc disease? Global Spine J. 2021: 2192568221998367.
[84] NAZARI L, SALEHPOUR S, HOSSEINI MS, et al. The effects of autologous platelet-rich plasma in repeated implantation failure: a randomized controlled trial. Hum Fertil (Camb). 2020;23(3):209-213.
[85] GAVRIIL L, DETOPOULOU M, PETSINI F, et al. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial. Br J Nutr. 2019; 121(9):982-991.
[86] MIROSHNYCHENKO O, CHALKLEY RJ, LEIB RD, et al. Proteomic analysis of platelet-rich and platelet-poor plasma. Regen Ther. 2020;15:226-235.
|